Mortality Prognostic Factors in Patients with Cutaneous Malignant Melanoma

<strong>Background:</strong> cutaneous malignant melanoma is the most lethal skin tumor, so it is important to know the risk factors for mortality in patients who suffer from it. <br /><strong>Objective:</strong> to determine the prognostic factors of mortality in patie...

Full description

Saved in:
Bibliographic Details
Main Authors: Víctor Ernesto González Velázquez, Lázaro Roque Pérez, Elys María Pedraza Rodríguez, Lissi Lisbet Rodríguez Rodríguez, Mabel González Escudero
Format: Article
Language:Spanish
Published: Universidad de las Ciencias Médicas de Cienfuegos 2021-01-01
Series:Revista Finlay
Subjects:
Online Access:https://revfinlay.sld.cu/index.php/finlay/article/view/868
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832577434718830592
author Víctor Ernesto González Velázquez
Lázaro Roque Pérez
Elys María Pedraza Rodríguez
Lissi Lisbet Rodríguez Rodríguez
Mabel González Escudero
author_facet Víctor Ernesto González Velázquez
Lázaro Roque Pérez
Elys María Pedraza Rodríguez
Lissi Lisbet Rodríguez Rodríguez
Mabel González Escudero
author_sort Víctor Ernesto González Velázquez
collection DOAJ
description <strong>Background:</strong> cutaneous malignant melanoma is the most lethal skin tumor, so it is important to know the risk factors for mortality in patients who suffer from it. <br /><strong>Objective:</strong> to determine the prognostic factors of mortality in patients with cutaneous malignant melanoma diagnosed and treated at the Celestino Hernández Robau Teaching University Hospital between January 2010 and December 2015. <br /><strong>Method:</strong> a retrospective cohort analytical observational study was carried out. The population consisted of all patients with cutaneous malignant melanoma diagnosed and treated at the Hospital in the study period (N = 142), and the sample was 112 patients. The variables analyzed were: age, sex, skin color, histological subtype, Breslow index, Clark level, mitotic index, lymph node involvement, distant metastasis, ulceration, topographic location, clinical stage, type of treatment, and lactate dehydrogenase levels blood at diagnosis. The Odds Ratio (OR) and its confidence intervals (CI) were determined for the statistically significant factors. The area under the ROC curve was evaluated for the quantitative variables and a multivariate analysis was performed using Binary Logistic Regression. It was a reliability of 95 %. <br /><strong>Results:</strong> the multivariate analysis identified as prognostic factors of mortality the Breslow index with a C statistic of 0.849 (CI: 0.770–0.923), the Clark V level (OR: 1.246; CI: 0.985-1.870), mitotic index ≥ 6mm2 (OR: 12.408; CI: 9.012-14.897), lymph node involvement ≥ 2 nodes (OR = 6.316; CI = 4.541-8.291), metastasis to lung or other viscera (OR: 6.206; CI: 4.342-8.001), tumor location on the head, neck or trunk (OR: 9.720; CI: 7.684-12.546), ulceration (OR: 0.528; CI: 0.120-0.856), non-surgical treatment (OR: 8.311; CI: 7.098-9.366) and the LDH value in blood ≥333 IU / l (OR: 18.905; CI: 14.750-21.053). <br /><strong>Conclusions:</strong> the prognostic factors of mortality in patients with a diagnosis of cutaneous malignant melanoma were the Breslow index, the Clark level, the mitotic index, lymph node involvement, metastases to the lung or other viscera, the location of the tumor in the head, neck or trunk, the presence of ulceration, non-surgical treatment and the highest values of LDH in blood.
format Article
id doaj-art-00221506cde543e8b175a581421843e0
institution Kabale University
issn 2221-2434
language Spanish
publishDate 2021-01-01
publisher Universidad de las Ciencias Médicas de Cienfuegos
record_format Article
series Revista Finlay
spelling doaj-art-00221506cde543e8b175a581421843e02025-01-30T21:22:00ZspaUniversidad de las Ciencias Médicas de CienfuegosRevista Finlay2221-24342021-01-011111022485Mortality Prognostic Factors in Patients with Cutaneous Malignant MelanomaVíctor Ernesto González Velázquez0Lázaro Roque Pérez1Elys María Pedraza Rodríguez2Lissi Lisbet Rodríguez Rodríguez3Mabel González Escudero4Instituto Superior de Ciencias Médicas de Villa Clara. Villa Clara.Instituto Superior de Ciencias Médicas de Villa Clara. Villa Clara.Instituto Superior de Ciencias Médicas de Villa Clara. Villa Clara.Instituto Superior de Ciencias Médicas de Villa Clara. Villa Clara.Instituto Superior de Ciencias Médicas de Villa Clara. Villa Clara.<strong>Background:</strong> cutaneous malignant melanoma is the most lethal skin tumor, so it is important to know the risk factors for mortality in patients who suffer from it. <br /><strong>Objective:</strong> to determine the prognostic factors of mortality in patients with cutaneous malignant melanoma diagnosed and treated at the Celestino Hernández Robau Teaching University Hospital between January 2010 and December 2015. <br /><strong>Method:</strong> a retrospective cohort analytical observational study was carried out. The population consisted of all patients with cutaneous malignant melanoma diagnosed and treated at the Hospital in the study period (N = 142), and the sample was 112 patients. The variables analyzed were: age, sex, skin color, histological subtype, Breslow index, Clark level, mitotic index, lymph node involvement, distant metastasis, ulceration, topographic location, clinical stage, type of treatment, and lactate dehydrogenase levels blood at diagnosis. The Odds Ratio (OR) and its confidence intervals (CI) were determined for the statistically significant factors. The area under the ROC curve was evaluated for the quantitative variables and a multivariate analysis was performed using Binary Logistic Regression. It was a reliability of 95 %. <br /><strong>Results:</strong> the multivariate analysis identified as prognostic factors of mortality the Breslow index with a C statistic of 0.849 (CI: 0.770–0.923), the Clark V level (OR: 1.246; CI: 0.985-1.870), mitotic index ≥ 6mm2 (OR: 12.408; CI: 9.012-14.897), lymph node involvement ≥ 2 nodes (OR = 6.316; CI = 4.541-8.291), metastasis to lung or other viscera (OR: 6.206; CI: 4.342-8.001), tumor location on the head, neck or trunk (OR: 9.720; CI: 7.684-12.546), ulceration (OR: 0.528; CI: 0.120-0.856), non-surgical treatment (OR: 8.311; CI: 7.098-9.366) and the LDH value in blood ≥333 IU / l (OR: 18.905; CI: 14.750-21.053). <br /><strong>Conclusions:</strong> the prognostic factors of mortality in patients with a diagnosis of cutaneous malignant melanoma were the Breslow index, the Clark level, the mitotic index, lymph node involvement, metastases to the lung or other viscera, the location of the tumor in the head, neck or trunk, the presence of ulceration, non-surgical treatment and the highest values of LDH in blood.https://revfinlay.sld.cu/index.php/finlay/article/view/868neoplasias cutáneasmelanomadiagnósticomortalidad
spellingShingle Víctor Ernesto González Velázquez
Lázaro Roque Pérez
Elys María Pedraza Rodríguez
Lissi Lisbet Rodríguez Rodríguez
Mabel González Escudero
Mortality Prognostic Factors in Patients with Cutaneous Malignant Melanoma
Revista Finlay
neoplasias cutáneas
melanoma
diagnóstico
mortalidad
title Mortality Prognostic Factors in Patients with Cutaneous Malignant Melanoma
title_full Mortality Prognostic Factors in Patients with Cutaneous Malignant Melanoma
title_fullStr Mortality Prognostic Factors in Patients with Cutaneous Malignant Melanoma
title_full_unstemmed Mortality Prognostic Factors in Patients with Cutaneous Malignant Melanoma
title_short Mortality Prognostic Factors in Patients with Cutaneous Malignant Melanoma
title_sort mortality prognostic factors in patients with cutaneous malignant melanoma
topic neoplasias cutáneas
melanoma
diagnóstico
mortalidad
url https://revfinlay.sld.cu/index.php/finlay/article/view/868
work_keys_str_mv AT victorernestogonzalezvelazquez mortalityprognosticfactorsinpatientswithcutaneousmalignantmelanoma
AT lazaroroqueperez mortalityprognosticfactorsinpatientswithcutaneousmalignantmelanoma
AT elysmariapedrazarodriguez mortalityprognosticfactorsinpatientswithcutaneousmalignantmelanoma
AT lissilisbetrodriguezrodriguez mortalityprognosticfactorsinpatientswithcutaneousmalignantmelanoma
AT mabelgonzalezescudero mortalityprognosticfactorsinpatientswithcutaneousmalignantmelanoma